Overall, our results are consistent with the previously described lack of significant differences in gene expression between del(5q) and non-del(5q) cells, suggesting that deregulation of hematopoiesis in patients with 5q MDS affects all CD34+ cells. The gene discussed is CD34; the disease is myelodysplastic syndrome.